News Releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Jul 24, 2017
BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedics medicines company specializing in therapeutics based on its proprietary hyaluronic acid...
-
Jul 17, 2017Company Expects Total Revenue Growth of 23% to 26% for Q2 2017
BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedics medicines company specializing in therapeutics based on its proprietary hyaluronic acid...
-
Jul 12, 2017
BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc. (NASDAQ: ANIK) today announced that the Company plans to issue its second-quarter 2017 financial results after the close of the market on...
-
Jul 6, 2017
BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedics medicines company specializing in therapeutics based on its proprietary hyaluronic acid...
-
May 30, 2017
BEDFORD, Mass. & VIENNA--(BUSINESS WIRE)-- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedics medicines company specializing in therapeutics based on its proprietary...
-
May 25, 2017
BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedics medicines company specializing in therapeutics based on its proprietary hyaluronic acid...
-
May 23, 2017Ribbon-Cutting Ceremony Opens the Doors to State-of-the-Art Facility Built to Supply Global Demand for Anika's Extensive Commercial Portfolio of More than 20 Products and Technologies
BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedics medicines company specializing in therapeutics based on its proprietary hyaluronic acid...
-
May 22, 2017Positive Data Provides Further Rationale for Strong and Growing Physician Demand for CINGAL following Commercial Launches in Europe and Canada
BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedics medicines company specializing in therapeutics based on its proprietary hyaluronic acid...
May 3, 2017MONOVISC Revenue Increases 24% Year-over-YearBEDFORD, Mass., May 03, 2017 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ:ANIK), a global, integrated orthopedic medicines company specializing in therapeutics based on its proprietary...
-
Apr 19, 2017
BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc. (NASDAQ: ANIK) today announced that the Company plans to issue its first-quarter 2017 financial results after the close of the market on...
-
Feb 28, 2017
BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedic medicines company specializing in therapeutics based on its proprietary hyaluronic acid ("HA"
-
Feb 15, 2017Worldwide Orthobiologics Revenue Increases 13% Year-over-Year for Fourth Quarter of 2016
BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedic medicines company specializing in therapeutics based on its proprietary hyaluronic acid ("HA"
-
Feb 1, 2017
BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc. (NASDAQ: ANIK) today announced that the Company plans to issue its fourth-quarter 2016 financial results after the close of the market on...
-
Dec 19, 2016
BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc., (NASDAQ: ANIK), a global, integrated orthopedic medicines company specializing in therapeutics based on its proprietary hyaluronic acid "HA"
-
Nov 15, 2016
BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedic medicines company specializing in therapeutics based on its proprietary hyaluronic acid ("HA"
-
Oct 26, 2016Worldwide Orthobiologics Revenue Increases 10% Year-over-Year
BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedic medicines company specializing in therapeutics based on its proprietary hyaluronic acid ("HA"
-
Oct 12, 2016Anika to Issue Third-Quarter 2016 Financial Results and Business Highlights on Wednesday, October 26
BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc. (NASDAQ: ANIK) today announced that the Company plans to issue its third-quarter 2016 financial results after the close of the market on...
-
Sep 22, 2016-- Podium Sessions Showcase Studies Comparing HYALOFAST versus Collagen Scaffold and Microfracture Surgery for Cartilage Repair --
BEDFORD, Mass. & NAPLES, Italy--(BUSINESS WIRE)-- Anika Therapeutics, Inc., (NASDAQ: ANIK), a global, integrated orthopedics medicines company specializing in therapeutics based on its proprietary...
-
Aug 25, 2016
BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedic medicines company specializing in therapeutics based on its proprietary hyaluronic acid ("HA"
-
Jul 27, 2016Total Revenue Increases 16% Year-over-Year
BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedic medicines company specializing in therapeutics based on its proprietary hyaluronic acid ("HA"
-
Jul 13, 2016
BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc. (NASDAQ: ANIK) today announced that the Company plans to issue its second-quarter 2016 financial results after the close of the market on...
-
Jun 2, 2016
BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc., (NASDAQ: ANIK), a global, integrated orthopedics medicines company specializing in therapeutics based on its proprietary hyaluronic acid...
-
Jun 1, 2016
BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc., (NASDAQ: ANIK), a global, integrated orthopedics medicines company specializing in therapeutics based on its proprietary hyaluronic acid...
-
May 19, 2016
BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc., (NASDAQ: ANIK), a global, integrated orthopedics medicines company specializing in therapeutics based on its proprietary hyaluronic acid...
-
Apr 27, 2016Total Revenue Increased 44% Year-over-Year
BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedic medicines company specializing in therapeutics based on its proprietary hyaluronic acid ("HA"
-
Apr 13, 2016
BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc. (NASDAQ: ANIK) today announced that the Company plans to issue its first-quarter 2016 financial results after the close of the market on...
-
Apr 4, 2016Expansion of Commercial Unit Includes Hire of New Vice President of Marketing
BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc., (NASDAQ: ANIK), a global, integrated orthopedics medicines company specializing in therapeutics based on its proprietary hyaluronic acid...
-
Mar 28, 2016
BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc., (NASDAQ: ANIK), a global, integrated orthopedics medicines company specializing in therapeutics based on its proprietary hyaluronic acid...
-
Feb 24, 2016Product Revenue Increased 43% Year-over-Year for Fourth Quarter of 2015
BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedic medicines company specializing in therapeutics based on its proprietary hyaluronic acid ("HA"
-
Feb 24, 2016
BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc., (NASDAQ: ANIK), a global, integrated orthopedics medicines company specializing in therapeutics based on its proprietary hyaluronic acid...
-
Feb 17, 2016
BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc., (NASDAQ: ANIK), a global, integrated orthopedic medicines company specializing in therapeutics based on its proprietary hyaluronic acid...
-
Feb 10, 2016
BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc. (Nasdaq: ANIK) today announced that the Company plans to issue its fourth-quarter 2015 financial results after the close of the market on...
-
Dec 29, 2015Cartilage Regeneration Therapy Builds Upon Company's Orthobiologics Experience, Representing Expansion into Field of Regenerative Medicine
BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc., (NASDAQ: ANIK), a global, integrated orthopedics medicines company specializing in therapeutics based on its proprietary hyaluronic acid...
-
Dec 9, 2015
BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc., (NASDAQ: ANIK), a global, integrated orthopedics medicines company specializing in therapeutics based on its proprietary hyaluronic acid...
-
Nov 19, 2015
BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc., (NASDAQ: ANIK), a global, integrated orthopedics medicines company specializing in therapeutics based on its proprietary hyaluronic acid...
-
Nov 3, 2015Achieves First Approval for Innovative Therapy Combining Hyaluronic Acid Technology with FDA-Approved Steroid
BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc., (NASDAQ: ANIK), a global, integrated orthopedics medicines company specializing in therapeutics based on its proprietary hyaluronic acid...
-
Oct 29, 2015Industry Veteran to Oversee Further Global Expansion of Commercial Platform, Strengthening of Commercial Partnerships, and Development of Direct Commercial Capability
BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc., (NASDAQ: ANIK), a global, integrated orthopedics medicines company specializing in therapeutics based on its proprietary hyaluronic acid...
-
Oct 28, 2015Company Achieves 37.5% Year-over-Year Diluted EPS Growth in Quarter
BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedics medicines company specializing in therapeutics based on its proprietary hyaluronic acid...
-
Oct 14, 2015
BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc. (Nasdaq: ANIK) today announced that the Company plans to issue its third-quarter 2015 financial results after the close of the market on...
-
Aug 19, 2015
Anika Therapeutics, Inc. Ranked #90 on Fortune's Fastest-Growing Companies for 2015
-
Jul 29, 2015Strength in Quarter Driven by Continued Adoption of Orthobiologics Products;
BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc. (NASDAQ: ANIK), a leader in products for tissue protection, healing, and repair based on hyaluronic acid (HA) technology, today reported...
-
Jul 15, 2015
BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc. (Nasdaq: ANIK) today announced that the Company plans to issue its second-quarter 2015 financial results after the close of the market on...
-
Jul 9, 2015
BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc., (NASDAQ: ANIK), a leader in products for tissue protection, healing, and repair based on hyaluronic acid (HA) technology, today reported...
-
Jun 23, 2015Study to be Sponsored by Company's Exclusive U.S. Distributor and Commercial Partner, DePuy Synthes Mitek Sports Medicine
BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc., (NASDAQ: ANIK), a leader in products for tissue protection, healing, and repair based on hyaluronic acid (HA) technology today announced...
-
Jun 17, 2015Research Collaboration to Focus on Innovative Therapy for Rheumatoid Arthritis
BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc., (NASDAQ: ANIK), a leader in products for tissue protection, healing, and repair based on hyaluronic acid (HA) technology, today...
-
May 21, 2015
BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc. (Nasdaq: ANIK) today announced that its President and Chief Executive Officer, Charles H. Sherwood, Ph.D., will make a presentation at...
-
Apr 28, 2015
Anika Therapeutics CEO Dr. Charles H. Sherwood to be Honored at UMass Amherst Undergraduate Commencement Ceremony on May 8
-
Apr 28, 2015Product Revenue Grows 8% to $15.5 Million
BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc. (Nasdaq: ANIK), a leader in products for tissue protection, healing, and repair, based on hyaluronic acid (HA) technology, today reported...
-
Apr 28, 2015Research Demonstrates Positive Clinical Outcomes for Hyalofast®
BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc. (Nasdaq: ANIK), a leader in products for tissue protection, healing, and repair based on hyaluronic acid (HA) technology, today announced...
-
Apr 17, 2015
BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc. (Nasdaq: ANIK), a leader in products for tissue protection, healing, and repair based on hyaluronic acid (HA) technology, today announced...
-
Apr 15, 2015
BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc. (Nasdaq: ANIK) today announced that it plans to issue its first-quarter 2015 financial results after the close of the market on Tuesday,...
-
Apr 10, 2015
BEDFORD, Mass.--(BUSINESS WIRE)-- Hyalomatrix, a unique advanced wound care device based on hyaluronic acid (HA) technology, is now eligible for reimbursement as a skin substitute through the...
-
Apr 8, 2015CE Marked Cartilage Regeneration Product Has Demonstrated Positive Outcomes Internationally
BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc. (Nasdaq: ANIK), a leader in products for tissue protection, healing, and repair based on hyaluronic acid (HA) technology, today announced...
-
Mar 17, 2015
BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc. (Nasdaq: ANIK) today announced that its President and Chief Executive Officer, Charles H. Sherwood, Ph.D., will be presenting at the 10th...
-
Feb 25, 2015Monovisc® Receives Unique J-Code Assignment from CMS Effective January 1, 2015
BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc. (Nasdaq: ANIK), a leader in products for tissue protection, healing and repair based on hyaluronic acid (HA) technology, today reported...
-
Feb 19, 2015
BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc. (Nasdaq: ANIK) today announced that it has appointed Glenn R. Larsen, Ph.D., as a new independent member of its Board of Directors. Dr....
-
Feb 12, 2015
BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc. (Nasdaq: ANIK) today announced that it plans to issue its fourth-quarter and year-end 2014 financial results after the close of the market on
-
Feb 11, 2015
BEDFORD, Mass--(BUSINESS WIRE)-- Anika Therapeutics, Inc. (Nasdaq: ANIK), a leader in products for tissue protection, healing and repair, based on hyaluronic acid (HA) technology, today announced...
-
Nov 10, 2014
BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc. (Nasdaq: ANIK) today announced that the Center for Medicare & Medicaid Services ("CMS") has assigned a unique Healthcare Common Procedure...
-
Oct 29, 2014Earnings per Share Increase to $0.40 from $0.33
BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc. (Nasdaq: ANIK), a leader in products for tissue protection, healing and repair, based on hyaluronic acid (HA) technology, today reported...
-
Oct 16, 2014
BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc. (Nasdaq: ANIK) today announced that it plans to issue its third-quarter 2014 financial results after the close of the market on...
-
Aug 4, 2014Presentation to be Webcast Live at 10:30 a.m. ET
BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc. (Nasdaq: ANIK) today announced that its President and Chief Executive Officer, Charles H. Sherwood, Ph.D., will be presenting at the...
-
Jul 30, 2014
BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc. (Nasdaq: ANIK) today announced that it has entered into a new agreement with Medline Industries, Inc. to commercialize the Company's...
-
Jul 30, 2014Total Revenue Grows 26% to $26.3 Million
BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc. (Nasdaq: ANIK), a leader in products for tissue protection, healing and repair, based on hyaluronic acid (HA) technology, today reported...
-
Jul 15, 2014
BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc. (Nasdaq: ANIK) today announced that it plans to issue its second-quarter 2014 financial results after the close of the market on...
-
Apr 29, 2014Receives $17.5 Million in Monovisc® Milestone Payment
BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc. (Nasdaq: ANIK), a leader in products for tissue protection, healing and repair, based on hyaluronic acid ("HA") technology, today...
-
Apr 16, 2014
BEDFORD, Mass--(BUSINESS WIRE)-- Anika Therapeutics, Inc. (Nasdaq: ANIK) today announced that it plans to issue its first-quarter 2014 financial results after the close of the market on Tuesday,...
-
Apr 15, 2014Company's Commercial Partner, DePuy Synthes Mitek Sports Medicine, Records First Commercial Sale of Single-Injection Treatment for Osteoarthritis Knee Pain
BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc. (Nasdaq: ANIK), a leader in products for tissue protection, healing and repair, based on hyaluronic acid ("HA") technology, today...
-
Mar 13, 2014
BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc. (Nasdaq: ANIK), a leader in products for tissue protection, healing and repair, based on hyaluronic acid ("HA") technology, today...
-
Mar 4, 2014
BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc. (Nasdaq: ANIK) today announced that its President and Chief Executive Officer, Charles H. Sherwood, Ph.D., will be presenting at the 9th...
-
Feb 26, 2014Monovisc® Achieves FDA Approval
BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc. (Nasdaq: ANIK), a leader in products for tissue protection, healing and repair, based on hyaluronic acid ("HA") technology, today...
-
Feb 25, 2014
BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc. (NASDAQ:ANIK) today announced it has received marketing approval for MONOVISC® from the U.S. Food and Drug Administration (FDA)....
-
Feb 12, 2014
BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc. (Nasdaq: ANIK) today announced that it plans to issue its fourth-quarter and year-end 2013 financial results after the close of the market on
-
Jan 9, 2014
Anika Therapeutics to Present at the Tenth Annual Noble Financial Equity Conference on January 20 BEDFORD, Mass. --(BUSINESS WIRE)--Jan. 9, 2014-- Anika Therapeutics, Inc. (Nasdaq: ANIK) a leader...
-
Oct 30, 2013TOTAL REVENUE GROWS TO $17.8 MILLION
BEDFORD, Mass. --(BUSINESS WIRE)--Oct. 30, 2013-- Anika Therapeutics, Inc. (Nasdaq: ANIK), a leader in products for tissue protection, healing and repair, based on hyaluronic acid (“HA”)...
-
Oct 15, 2013
Anika Therapeutics Announces Date of Third-Quarter 2013 Financial Results Conference Call BEDFORD, Mass. --(BUSINESS WIRE)--Oct. 15, 2013-- Anika Therapeutics, Inc. (Nasdaq: ANIK) today announced...
-
Oct 2, 2013
Anika Therapeutics Appoints Industry-Recognized R&D Executive John W. Sheets, Jr., Ph.D. as Chief Scientific Officer BEDFORD, Mass. --(BUSINESS WIRE)--Oct. 2, 2013-- Anika Therapeutics, Inc....
-
Aug 16, 2013
Anika Therapeutics to Present at the Rodman & Renshaw Annual Global Investment Conference on September 10 BEDFORD, Mass. --(BUSINESS WIRE)--Aug. 16, 2013-- Anika Therapeutics, Inc. (Nasdaq: ANIK)...
-
Aug 13, 2013
Anika Therapeutics to Present at the Midwest IDEAS Conference on August 27 BEDFORD, Mass. --(BUSINESS WIRE)--Aug. 13, 2013-- Anika Therapeutics, Inc. (Nasdaq: ANIK) a leader in products for tissue...
-
Jul 31, 2013NET INCOME GROWS 58% AND EPS RISE TO $0.40
BEDFORD, Mass. --(BUSINESS WIRE)--Jul. 31, 2013-- Anika Therapeutics, Inc. (Nasdaq: ANIK), a leader in products for tissue protection, healing and repair, based on hyaluronic acid (“HA”)...
-
Jul 12, 2013
Anika Therapeutics Announces Date of Second-Quarter 2013 Financial Results Conference Call BEDFORD, Mass. --(BUSINESS WIRE)--Jul. 12, 2013-- Anika Therapeutics, Inc. (Nasdaq: ANIK) today announced...
-
May 1, 2013
Anika Therapeutics Reports First-Quarter 2013 Financial Results BEDFORD, Mass. --(BUSINESS WIRE)--May. 1, 2013-- Anika Therapeutics, Inc. (Nasdaq: ANIK), a leader in products for tissue...
-
Apr 5, 2013
Anika Therapeutics Announces Date of First-Quarter 2013 Financial Results Conference Call BEDFORD, Mass. --(BUSINESS WIRE)--Apr. 5, 2013-- Anika Therapeutics, Inc. (NASDAQ:ANIK) today announced...
-
Mar 13, 2013
Anika Therapeutics to Present at the Canaccord Genuity Musculoskeletal Conference on March 19 BEDFORD, Mass. --(BUSINESS WIRE)--Mar. 13, 2013-- Anika Therapeutics, Inc. (Nasdaq: ANIK) a leader in...
-
Feb 27, 2013FOURTH QUARTER REVENUE INCREASES 23% ON STRONG SALES OF ORTHOVISC
BEDFORD, Mass. --(BUSINESS WIRE)--Feb. 27, 2013-- Anika Therapeutics, Inc. (Nasdaq: ANIK), a leader in products for tissue protection, healing and repair, based on hyaluronic acid (“HA”)...
-
Feb 14, 2013
Anika Therapeutics Announces Date of Fourth-Quarter and Year-End 2012 Financial Results Conference Call BEDFORD, Mass. --(BUSINESS WIRE)--Feb. 14, 2013-- Anika Therapeutics, Inc. (Nasdaq: ANIK)...
-
Jan 22, 2013
Anika Therapeutics Names Sylvia Cheung as Chief Financial Officer BEDFORD, Mass. --(BUSINESS WIRE)--Jan. 22, 2013-- Anika Therapeutics, Inc. (Nasdaq: ANIK) today announced the appointment of...
-
Dec 4, 2012
Anika Therapeutics Announces Monovisc PMA News BEDFORD, Mass. --(BUSINESS WIRE)--Dec. 4, 2012-- Anika Therapeutics, Inc. (Nasdaq: ANIK) announced today that it has received correspondence from the...
-
Oct 30, 2012ACHIEVES REVENUE OF $14.8 MILLION, EARNINGS PER SHARE OF $0.11 AND CASH GENERATED FROM OPERATIONS OF $2.2 MILLION FOR THE QUARTER
BEDFORD, Mass. --(BUSINESS WIRE)--Oct. 30, 2012-- Anika Therapeutics, Inc. (Nasdaq: ANIK), a leader in products for tissue protection, healing and repair, based on hyaluronic acid (“HA”)...
-
Oct 29, 2012
Anika Therapeutics Postpones Release of Third-Quarter 2012 Financial Results to October 30 BEDFORD, Mass. --(BUSINESS WIRE)--Oct. 29, 2012-- Anika Therapeutics, Inc. (Nasdaq: ANIK) today announced...
-
Oct 18, 2012
Anika Therapeutics Announces Date of Third-Quarter 2012 Financial Results Conference Call BEDFORD, Mass. --(BUSINESS WIRE)--Oct. 18, 2012-- Anika Therapeutics, Inc. (Nasdaq: ANIK) today announced...
-
Aug 1, 2012
Anika Therapeutics Reports Record Second Quarter Revenue and Earnings BEDFORD, Mass. --(BUSINESS WIRE)--Aug. 1, 2012-- Anika Therapeutics, Inc. (Nasdaq: ANIK), a leader in products for tissue...
-
Jul 19, 2012
Anika Therapeutics Announces Date of Second-Quarter 2012 Financial Results Conference Call BEDFORD, Mass --(BUSINESS WIRE)--Jul. 19, 2012-- Anika Therapeutics, Inc. (Nasdaq: ANIK) today announced...
-
May 5, 2012
Anika Therapeutics Reports Record First-Quarter Revenue and Earnings BEDFORD, Mass. --(BUSINESS WIRE)--May. 3, 2012-- Anika Therapeutics, Inc. (Nasdaq: ANIK), a leader in products for tissue...
-
Apr 26, 2012
Anika Therapeutics Announces Date of First-Quarter 2012 Financial Results Conference CallBEDFORD, Mass., Apr 26, 2012 (BUSINESS WIRE) --Anika Therapeutics, Inc. (Nasdaq: ANIK) today announced that...
-
Feb 29, 2012EARNINGS MORE THAN DOUBLE TO 21¢ PER SHARE
BEDFORD, Mass. --(BUSINESS WIRE)--Feb. 29, 2012-- Anika Therapeutics, Inc. (Nasdaq: ANIK), a leader in products for tissue protection, healing, and repair, based on hyaluronic acid (“HA”)...
-
Feb 23, 2012
Anika Therapeutics Announces Date of Fourth-Quarter and Year-End 2011 Financial Results Conference Call BEDFORD, Mass. --(BUSINESS WIRE)--Feb. 23, 2012-- Anika Therapeutics, Inc. (Nasdaq: ANIK)...
-
Feb 2, 2012
Anika Therapeutics to Present at the Canaccord Genuity Musculoskeletal Conference on February 7 BEDFORD, Mass. --(BUSINESS WIRE)--Feb. 2, 2012-- Anika Therapeutics, Inc. (Nasdaq: ANIK) a leader in...
-
Jan 10, 2012
Anika Therapeutics to Present at the Eighth Annual Noble Financial Equity Conference on January 17 BEDFORD, Mass. --(BUSINESS WIRE)--Jan. 10, 2012-- Anika Therapeutics, Inc. (Nasdaq: ANIK) a...
-
Dec 21, 2011Anika Therapeutics Announces U.S. MONOVISC® License and Supply Agreement with DePuy Mitek, Inc.
BEDFORD, Mass.--(BUSINESS WIRE)--Dec. 21, 2011-- Anika Therapeutics, Inc. (NASDAQ:ANIK) today announced the signing of an exclusive, multi-year U.S. licensing and supply agreement with DePuy...